Nuclear Radiology: Page 25

Shine signs Czech license agreement

By AuntMinnieEurope.com staff writers

Medical isotope firm Shine Medical Technologies has signed an intellectual property license agreement with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague).

May 15, 2019

AI predicts myocardial infarction, death in patients at risk of CAD

By Erik L. Ridley

By analyzing clinical and hybrid imaging data, an artificial intelligence (AI) algorithm can predict which patients will go on to experience myocardial infarction or death during long-term follow-up, according to research from Finland presented at this week's International Conference on Nuclear Cardiology and Cardiac CT in Lisbon.

May 12, 2019

How to train the medical physicists of the future

By Tami Freeman, PhD

At the recent European Society for Radiotherapy and Oncology meeting in Milan, a debate examined the skills that medical physicists will require in 10 years' time and asked how training for medical physicists specializing in radiation oncology should develop over the next decade. Five expert speakers presented their thoughts -- and then let the audience decide.

May 9, 2019

EANM pitches supplier audit project

By AuntMinnieEurope.com staff writers

The European Association of Nuclear Medicine (EANM) is inviting companies involved in the manufacturing of PET radiopharmaceuticals to join its Shared Audit and Supplier Assessment Initiative.

May 7, 2019

ITM expands operations in Germany

By AuntMinnieEurope.com staff writers

German radiopharmaceutical firm ITM Isotopen Technologien München is set to increase its capacity to produce the medical isotope lutetium-177 at a facility in Neufahrn, Germany.

May 7, 2019

EMA publishes new guidance on radiopharmaceuticals

By AuntMinnieEurope.com staff writers

The European Medicines Agency (EMA) has published a draft guideline for nonclinical safety testing for radiopharmaceuticals, the European Association of Nuclear Medicine has announced.

May 2, 2019

New breast CAD advances detection with MRI, PET

By Wayne Forrest

Researchers from Austria have developed a new computer-aided segmentation and diagnostic (CAD) algorithm to distinguish between cancerous and benign breast lesions using PET and MRI data. Their study was published online on 27 April in European Radiology Experimental.

May 2, 2019

ANSTO secures molecular imaging partnership

By AuntMinnieEurope.com staff writers

The Australian Nuclear Science and Technology Organisation (ANSTO) has signed a strategic partnership with the University of Sydney.

April 23, 2019

Blue Earth's Axumin agent added to EAU guidelines

By AuntMinnieEurope.com staff writers

Molecular imaging firm Blue Earth Diagnostics said that its Axumin PET imaging agent has been added to the European Association of Urology (EAU) 2019 Clinical Practice Guidelines in Oncology for Prostate Cancer.

April 16, 2019

AC Immune highlights PET tracer results for Parkinson's

By AuntMinnieEurope.com staff writers

Swiss biopharmaceutical company AC Immune said a recent study concluded that its PET tracer showed potential for detecting and monitoring Parkinson's disease in humans.

April 14, 2019

Choline supply issues affect PET/CT studies in U.K.

By AuntMinnieEurope.com staff writers

Problems related to the supply of choline have led to delays and postponements for radiolabeled choline PET/CT scans in men suspected of having prostate cancer recurrence, according to a report published on 7 April in the Guardian.

April 9, 2019

United Imaging partners with ITM

By AuntMinnieEurope.com staff writers

Shanghai-based United Imaging Healthcare (UIH) has signed a worldwide strategic sales and marketing agreement with radiopharmaceutical supplier ITM Isotopen Technologien München.

April 2, 2019

Previous Page

Page 25 of 90

Next Page